The current climate has presented us with many issues and one of the greatest concerns is not many of us have visited a hospital for care during the COVID-19 pandemic. Given the significant disruption that COVID-19 caused to cancer diagnosis and treatment, combined with the changing shielding guidelines and as part of our continuing support of Cancer 52, we wanted to take part in a video to help put patients’ minds at ease if they were asked to go to hospital for treatment. We are also very pleased that Professor Peter Johnson, NHS England’s National Clinical Director for Cancer, took part.
I’m delighted that the video Cancer patients talk about their care has now been created featuring Pseudomyxoma Survivor trustee, Georgina. Please watch it and share it where you can as it is extremely important that this message is conveyed as much as possible at this time, not least for rare cancer patients.
If you have any signs or symptoms that are a matter of concern to you, we urge you to contact your doctor as soon as you can. Cancer doesn’t wait for a global pandemic to finish.
In December, Susan and Angela have been asked to present at the EuroPMP International Workshop on pseudomyxoma peritonei. It is a privilege to be asked to present to this network of experts from many fields, including surgeons, pathologists, oncologists, radiologists, molecular biologists, bioinformaticians and allied health care professionals of which Angela is a participant.
One of the connections we have made this year is with National Voices, the coalition of charities that stands for people being in control of their health and care. National Voice has drawn our attention to a new report published by Cancer Research UK, ‘Securing a cancer workforce for the best outcomes’.
One of the recommendations of the Charity Commission, the body that regulates charities in the UK, is that charities work with other charities. This is extremely important to the trustees of Pseudomyxoma Survivor and key to a lot of the things we do.